Pharma & Healthcare
Global Radiopharmaceutical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 198559
- Pages: 100
- Figures: 91
- Views: 1
The global Radiopharmaceutical market size was US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
The global Radiopharmaceutical market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng
By Type: (Dominant Segment vs High-Margin Innovation)
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
By Application: (Core Demand Driver vs Emerging Opportunity)
Oncology
Cardiology
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Cardinal Health in Europe)
- Emerging Product Trends: Diagnostic Radiopharmaceuticals adoption vs. Therapeutic Radiopharmaceuticals premiumization
- Demand-Side Dynamics: Oncology growth in China vs. Cardiology potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Radiopharmaceutical market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Therapeutic Radiopharmaceuticals in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cardiology in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Diagnostic Radiopharmaceuticals dominance in Europe vs. Therapeutic Radiopharmaceuticals demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
The global Radiopharmaceutical market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng
By Type: (Dominant Segment vs High-Margin Innovation)
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
By Application: (Core Demand Driver vs Emerging Opportunity)
Oncology
Cardiology
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Cardinal Health in Europe)
- Emerging Product Trends: Diagnostic Radiopharmaceuticals adoption vs. Therapeutic Radiopharmaceuticals premiumization
- Demand-Side Dynamics: Oncology growth in China vs. Cardiology potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Radiopharmaceutical market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Therapeutic Radiopharmaceuticals in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cardiology in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Diagnostic Radiopharmaceuticals dominance in Europe vs. Therapeutic Radiopharmaceuticals demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Radiopharmaceutical Product Scope
1.2 Radiopharmaceutical by Type
1.2.1 Global Radiopharmaceutical Sales by Type (2020 & 2024 & 2031)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapeutic Radiopharmaceuticals
1.3 Radiopharmaceutical by Application
1.3.1 Global Radiopharmaceutical Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market Estimates and Forecasts (2020-2031)
1.4.1 Global Radiopharmaceutical Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Radiopharmaceutical Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Radiopharmaceutical Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Radiopharmaceutical Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Radiopharmaceutical Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
2.2.2 Global Radiopharmaceutical Revenue Market Share by Region (2020-2025)
2.3 Global Radiopharmaceutical Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Radiopharmaceutical Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Radiopharmaceutical Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Radiopharmaceutical Market Size and Prospective (2020-2031)
2.4.2 Europe Radiopharmaceutical Market Size and Prospective (2020-2031)
2.4.3 China Radiopharmaceutical Market Size and Prospective (2020-2031)
2.4.4 Japan Radiopharmaceutical Market Size and Prospective (2020-2031)
2.4.5 India Radiopharmaceutical Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Radiopharmaceutical Historic Market Review by Type (2020-2025)
3.1.1 Global Radiopharmaceutical Sales by Type (2020-2025)
3.1.2 Global Radiopharmaceutical Revenue by Type (2020-2025)
3.1.3 Global Radiopharmaceutical Price by Type (2020-2025)
3.2 Global Radiopharmaceutical Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Radiopharmaceutical Sales Forecast by Type (2026-2031)
3.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2026-2031)
3.2.3 Global Radiopharmaceutical Price Forecast by Type (2026-2031)
3.3 Different Types Radiopharmaceutical Representative Players
4 Global Market Size by Application
4.1 Global Radiopharmaceutical Historic Market Review by Application (2020-2025)
4.1.1 Global Radiopharmaceutical Sales by Application (2020-2025)
4.1.2 Global Radiopharmaceutical Revenue by Application (2020-2025)
4.1.3 Global Radiopharmaceutical Price by Application (2020-2025)
4.2 Global Radiopharmaceutical Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Radiopharmaceutical Sales Forecast by Application (2026-2031)
4.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2026-2031)
4.2.3 Global Radiopharmaceutical Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Radiopharmaceutical Application
5 Competition Landscape by Players
5.1 Global Radiopharmaceutical Sales by Players (2020-2025)
5.2 Global Top Radiopharmaceutical Players by Revenue (2020-2025)
5.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)
5.4 Global Radiopharmaceutical Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Radiopharmaceutical, Product Type & Application
5.7 Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Radiopharmaceutical Sales by Company
6.1.1.1 North America Radiopharmaceutical Sales by Company (2020-2025)
6.1.1.2 North America Radiopharmaceutical Revenue by Company (2020-2025)
6.1.2 North America Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.1.3 North America Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.1.4 North America Radiopharmaceutical Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Radiopharmaceutical Sales by Company
6.2.1.1 Europe Radiopharmaceutical Sales by Company (2020-2025)
6.2.1.2 Europe Radiopharmaceutical Revenue by Company (2020-2025)
6.2.2 Europe Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.2.3 Europe Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.2.4 Europe Radiopharmaceutical Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Radiopharmaceutical Sales by Company
6.3.1.1 China Radiopharmaceutical Sales by Company (2020-2025)
6.3.1.2 China Radiopharmaceutical Revenue by Company (2020-2025)
6.3.2 China Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.3.3 China Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.3.4 China Radiopharmaceutical Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Radiopharmaceutical Sales by Company
6.4.1.1 Japan Radiopharmaceutical Sales by Company (2020-2025)
6.4.1.2 Japan Radiopharmaceutical Revenue by Company (2020-2025)
6.4.2 Japan Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.4.3 Japan Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.4.4 Japan Radiopharmaceutical Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Radiopharmaceutical Sales by Company
6.5.1.1 India Radiopharmaceutical Sales by Company (2020-2025)
6.5.1.2 India Radiopharmaceutical Revenue by Company (2020-2025)
6.5.2 India Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.5.3 India Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.5.4 India Radiopharmaceutical Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Cardinal Health
7.1.1 Cardinal Health Company Information
7.1.2 Cardinal Health Business Overview
7.1.3 Cardinal Health Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Cardinal Health Radiopharmaceutical Products Offered
7.1.5 Cardinal Health Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Information
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.2.4 GE Healthcare Radiopharmaceutical Products Offered
7.2.5 GE Healthcare Recent Development
7.3 Jubilant Pharma
7.3.1 Jubilant Pharma Company Information
7.3.2 Jubilant Pharma Business Overview
7.3.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Jubilant Pharma Radiopharmaceutical Products Offered
7.3.5 Jubilant Pharma Recent Development
7.4 Novartis
7.4.1 Novartis Company Information
7.4.2 Novartis Business Overview
7.4.3 Novartis Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Novartis Radiopharmaceutical Products Offered
7.4.5 Novartis Recent Development
7.5 Curium Pharma
7.5.1 Curium Pharma Company Information
7.5.2 Curium Pharma Business Overview
7.5.3 Curium Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Curium Pharma Radiopharmaceutical Products Offered
7.5.5 Curium Pharma Recent Development
7.6 SIEMENS
7.6.1 SIEMENS Company Information
7.6.2 SIEMENS Business Overview
7.6.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.6.4 SIEMENS Radiopharmaceutical Products Offered
7.6.5 SIEMENS Recent Development
7.7 Lantheus
7.7.1 Lantheus Company Information
7.7.2 Lantheus Business Overview
7.7.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Lantheus Radiopharmaceutical Products Offered
7.7.5 Lantheus Recent Development
7.8 Bracco Imaging
7.8.1 Bracco Imaging Company Information
7.8.2 Bracco Imaging Business Overview
7.8.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Bracco Imaging Radiopharmaceutical Products Offered
7.8.5 Bracco Imaging Recent Development
7.9 Bayer
7.9.1 Bayer Company Information
7.9.2 Bayer Business Overview
7.9.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Bayer Radiopharmaceutical Products Offered
7.9.5 Bayer Recent Development
7.10 Eli Lilly
7.10.1 Eli Lilly Company Information
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Eli Lilly Radiopharmaceutical Products Offered
7.10.5 Eli Lilly Recent Development
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Company Information
7.11.2 Aurobindo Pharma Business Overview
7.11.3 Aurobindo Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Aurobindo Pharma Radiopharmaceutical Products Offered
7.11.5 Aurobindo Pharma Recent Development
7.12 Mundipharma
7.12.1 Mundipharma Company Information
7.12.2 Mundipharma Business Overview
7.12.3 Mundipharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Mundipharma Radiopharmaceutical Products Offered
7.12.5 Mundipharma Recent Development
7.13 China Isotope & Radiation
7.13.1 China Isotope & Radiation Company Information
7.13.2 China Isotope & Radiation Business Overview
7.13.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.13.4 China Isotope & Radiation Radiopharmaceutical Products Offered
7.13.5 China Isotope & Radiation Recent Development
7.14 Dongcheng
7.14.1 Dongcheng Company Information
7.14.2 Dongcheng Business Overview
7.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Dongcheng Radiopharmaceutical Products Offered
7.14.5 Dongcheng Recent Development
8 Radiopharmaceutical Manufacturing Cost Analysis
8.1 Radiopharmaceutical Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Radiopharmaceutical
8.4 Radiopharmaceutical Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Radiopharmaceutical Distributors List
9.3 Radiopharmaceutical Customers
10 Radiopharmaceutical Market Dynamics
10.1 Radiopharmaceutical Industry Trends
10.2 Radiopharmaceutical Market Drivers
10.3 Radiopharmaceutical Market Challenges
10.4 Radiopharmaceutical Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Radiopharmaceutical Product Scope
1.2 Radiopharmaceutical by Type
1.2.1 Global Radiopharmaceutical Sales by Type (2020 & 2024 & 2031)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapeutic Radiopharmaceuticals
1.3 Radiopharmaceutical by Application
1.3.1 Global Radiopharmaceutical Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market Estimates and Forecasts (2020-2031)
1.4.1 Global Radiopharmaceutical Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Radiopharmaceutical Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Radiopharmaceutical Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Radiopharmaceutical Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Radiopharmaceutical Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
2.2.2 Global Radiopharmaceutical Revenue Market Share by Region (2020-2025)
2.3 Global Radiopharmaceutical Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Radiopharmaceutical Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Radiopharmaceutical Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Radiopharmaceutical Market Size and Prospective (2020-2031)
2.4.2 Europe Radiopharmaceutical Market Size and Prospective (2020-2031)
2.4.3 China Radiopharmaceutical Market Size and Prospective (2020-2031)
2.4.4 Japan Radiopharmaceutical Market Size and Prospective (2020-2031)
2.4.5 India Radiopharmaceutical Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Radiopharmaceutical Historic Market Review by Type (2020-2025)
3.1.1 Global Radiopharmaceutical Sales by Type (2020-2025)
3.1.2 Global Radiopharmaceutical Revenue by Type (2020-2025)
3.1.3 Global Radiopharmaceutical Price by Type (2020-2025)
3.2 Global Radiopharmaceutical Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Radiopharmaceutical Sales Forecast by Type (2026-2031)
3.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2026-2031)
3.2.3 Global Radiopharmaceutical Price Forecast by Type (2026-2031)
3.3 Different Types Radiopharmaceutical Representative Players
4 Global Market Size by Application
4.1 Global Radiopharmaceutical Historic Market Review by Application (2020-2025)
4.1.1 Global Radiopharmaceutical Sales by Application (2020-2025)
4.1.2 Global Radiopharmaceutical Revenue by Application (2020-2025)
4.1.3 Global Radiopharmaceutical Price by Application (2020-2025)
4.2 Global Radiopharmaceutical Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Radiopharmaceutical Sales Forecast by Application (2026-2031)
4.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2026-2031)
4.2.3 Global Radiopharmaceutical Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Radiopharmaceutical Application
5 Competition Landscape by Players
5.1 Global Radiopharmaceutical Sales by Players (2020-2025)
5.2 Global Top Radiopharmaceutical Players by Revenue (2020-2025)
5.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)
5.4 Global Radiopharmaceutical Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Radiopharmaceutical, Product Type & Application
5.7 Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Radiopharmaceutical Sales by Company
6.1.1.1 North America Radiopharmaceutical Sales by Company (2020-2025)
6.1.1.2 North America Radiopharmaceutical Revenue by Company (2020-2025)
6.1.2 North America Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.1.3 North America Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.1.4 North America Radiopharmaceutical Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Radiopharmaceutical Sales by Company
6.2.1.1 Europe Radiopharmaceutical Sales by Company (2020-2025)
6.2.1.2 Europe Radiopharmaceutical Revenue by Company (2020-2025)
6.2.2 Europe Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.2.3 Europe Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.2.4 Europe Radiopharmaceutical Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Radiopharmaceutical Sales by Company
6.3.1.1 China Radiopharmaceutical Sales by Company (2020-2025)
6.3.1.2 China Radiopharmaceutical Revenue by Company (2020-2025)
6.3.2 China Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.3.3 China Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.3.4 China Radiopharmaceutical Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Radiopharmaceutical Sales by Company
6.4.1.1 Japan Radiopharmaceutical Sales by Company (2020-2025)
6.4.1.2 Japan Radiopharmaceutical Revenue by Company (2020-2025)
6.4.2 Japan Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.4.3 Japan Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.4.4 Japan Radiopharmaceutical Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Radiopharmaceutical Sales by Company
6.5.1.1 India Radiopharmaceutical Sales by Company (2020-2025)
6.5.1.2 India Radiopharmaceutical Revenue by Company (2020-2025)
6.5.2 India Radiopharmaceutical Sales Breakdown by Type (2020-2025)
6.5.3 India Radiopharmaceutical Sales Breakdown by Application (2020-2025)
6.5.4 India Radiopharmaceutical Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Cardinal Health
7.1.1 Cardinal Health Company Information
7.1.2 Cardinal Health Business Overview
7.1.3 Cardinal Health Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Cardinal Health Radiopharmaceutical Products Offered
7.1.5 Cardinal Health Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Information
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.2.4 GE Healthcare Radiopharmaceutical Products Offered
7.2.5 GE Healthcare Recent Development
7.3 Jubilant Pharma
7.3.1 Jubilant Pharma Company Information
7.3.2 Jubilant Pharma Business Overview
7.3.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Jubilant Pharma Radiopharmaceutical Products Offered
7.3.5 Jubilant Pharma Recent Development
7.4 Novartis
7.4.1 Novartis Company Information
7.4.2 Novartis Business Overview
7.4.3 Novartis Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Novartis Radiopharmaceutical Products Offered
7.4.5 Novartis Recent Development
7.5 Curium Pharma
7.5.1 Curium Pharma Company Information
7.5.2 Curium Pharma Business Overview
7.5.3 Curium Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Curium Pharma Radiopharmaceutical Products Offered
7.5.5 Curium Pharma Recent Development
7.6 SIEMENS
7.6.1 SIEMENS Company Information
7.6.2 SIEMENS Business Overview
7.6.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.6.4 SIEMENS Radiopharmaceutical Products Offered
7.6.5 SIEMENS Recent Development
7.7 Lantheus
7.7.1 Lantheus Company Information
7.7.2 Lantheus Business Overview
7.7.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Lantheus Radiopharmaceutical Products Offered
7.7.5 Lantheus Recent Development
7.8 Bracco Imaging
7.8.1 Bracco Imaging Company Information
7.8.2 Bracco Imaging Business Overview
7.8.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Bracco Imaging Radiopharmaceutical Products Offered
7.8.5 Bracco Imaging Recent Development
7.9 Bayer
7.9.1 Bayer Company Information
7.9.2 Bayer Business Overview
7.9.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Bayer Radiopharmaceutical Products Offered
7.9.5 Bayer Recent Development
7.10 Eli Lilly
7.10.1 Eli Lilly Company Information
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Eli Lilly Radiopharmaceutical Products Offered
7.10.5 Eli Lilly Recent Development
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Company Information
7.11.2 Aurobindo Pharma Business Overview
7.11.3 Aurobindo Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Aurobindo Pharma Radiopharmaceutical Products Offered
7.11.5 Aurobindo Pharma Recent Development
7.12 Mundipharma
7.12.1 Mundipharma Company Information
7.12.2 Mundipharma Business Overview
7.12.3 Mundipharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Mundipharma Radiopharmaceutical Products Offered
7.12.5 Mundipharma Recent Development
7.13 China Isotope & Radiation
7.13.1 China Isotope & Radiation Company Information
7.13.2 China Isotope & Radiation Business Overview
7.13.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.13.4 China Isotope & Radiation Radiopharmaceutical Products Offered
7.13.5 China Isotope & Radiation Recent Development
7.14 Dongcheng
7.14.1 Dongcheng Company Information
7.14.2 Dongcheng Business Overview
7.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Dongcheng Radiopharmaceutical Products Offered
7.14.5 Dongcheng Recent Development
8 Radiopharmaceutical Manufacturing Cost Analysis
8.1 Radiopharmaceutical Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Radiopharmaceutical
8.4 Radiopharmaceutical Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Radiopharmaceutical Distributors List
9.3 Radiopharmaceutical Customers
10 Radiopharmaceutical Market Dynamics
10.1 Radiopharmaceutical Industry Trends
10.2 Radiopharmaceutical Market Drivers
10.3 Radiopharmaceutical Market Challenges
10.4 Radiopharmaceutical Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceutical Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Radiopharmaceutical Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Radiopharmaceutical Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Radiopharmaceutical Sales (K Dose) by Region (2020-2025)
Table 5. Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
Table 6. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Radiopharmaceutical Revenue Share by Region (2020-2025)
Table 8. Global Radiopharmaceutical Sales (K Dose) Forecast by Region (2026-2031)
Table 9. Global Radiopharmaceutical Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Radiopharmaceutical Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Radiopharmaceutical Revenue Share Forecast by Region (2026-2031)
Table 12. Global Radiopharmaceutical Sales by Type (K Dose) & (2020-2025)
Table 13. Global Radiopharmaceutical Sales Share by Type (2020-2025)
Table 14. Global Radiopharmaceutical Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Radiopharmaceutical Price by Type (USD/Dose) & (2020-2025)
Table 16. Global Radiopharmaceutical Sales by Type (K Dose) & (2026-2031)
Table 17. Global Radiopharmaceutical Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Radiopharmaceutical Price by Type (USD/Dose) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Radiopharmaceutical Sales by Application (K Dose) & (2020-2025)
Table 21. Global Radiopharmaceutical Sales Share by Application (2020-2025)
Table 22. Global Radiopharmaceutical Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Radiopharmaceutical Price by Application (USD/Dose) & (2020-2025)
Table 24. Global Radiopharmaceutical Sales by Application (K Dose) & (2026-2031)
Table 25. Global Radiopharmaceutical Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Radiopharmaceutical Price by Application (USD/Dose) & (2026-2031)
Table 27. New Sources of Growth in Radiopharmaceutical Application
Table 28. Global Radiopharmaceutical Sales by Company (K Dose) & (2020-2025)
Table 29. Global Radiopharmaceutical Sales Share by Company (2020-2025)
Table 30. Global Radiopharmaceutical Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Radiopharmaceutical Revenue Share by Company (2020-2025)
Table 32. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)
Table 33. Global Market Radiopharmaceutical Average Price by Company (USD/Dose) & (2020-2025)
Table 34. Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Radiopharmaceutical, Product Type & Application
Table 36. Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 39. North America Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 40. North America Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 42. North America Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 43. North America Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 44. North America Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 45. North America Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 46. Europe Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 47. Europe Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 48. Europe Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 50. Europe Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 51. Europe Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 52. Europe Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 53. Europe Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 54. China Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 55. China Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 56. China Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 58. China Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 59. China Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 60. China Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 61. China Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 62. Japan Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 63. Japan Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 64. Japan Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 66. Japan Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 67. Japan Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 68. Japan Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 69. Japan Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 70. India Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 71. India Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 72. India Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 74. India Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 75. India Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 76. India Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 77. India Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 78. Cardinal Health Company Information
Table 79. Cardinal Health Description and Business Overview
Table 80. Cardinal Health Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Cardinal Health Radiopharmaceutical Product
Table 82. Cardinal Health Recent Development
Table 83. GE Healthcare Company Information
Table 84. GE Healthcare Description and Business Overview
Table 85. GE Healthcare Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. GE Healthcare Radiopharmaceutical Product
Table 87. GE Healthcare Recent Development
Table 88. Jubilant Pharma Company Information
Table 89. Jubilant Pharma Description and Business Overview
Table 90. Jubilant Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Jubilant Pharma Radiopharmaceutical Product
Table 92. Jubilant Pharma Recent Development
Table 93. Novartis Company Information
Table 94. Novartis Description and Business Overview
Table 95. Novartis Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Novartis Radiopharmaceutical Product
Table 97. Novartis Recent Development
Table 98. Curium Pharma Company Information
Table 99. Curium Pharma Description and Business Overview
Table 100. Curium Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 101. Curium Pharma Radiopharmaceutical Product
Table 102. Curium Pharma Recent Development
Table 103. SIEMENS Company Information
Table 104. SIEMENS Description and Business Overview
Table 105. SIEMENS Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 106. SIEMENS Radiopharmaceutical Product
Table 107. SIEMENS Recent Development
Table 108. Lantheus Company Information
Table 109. Lantheus Description and Business Overview
Table 110. Lantheus Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 111. Lantheus Radiopharmaceutical Product
Table 112. Lantheus Recent Development
Table 113. Bracco Imaging Company Information
Table 114. Bracco Imaging Description and Business Overview
Table 115. Bracco Imaging Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 116. Bracco Imaging Radiopharmaceutical Product
Table 117. Bracco Imaging Recent Development
Table 118. Bayer Company Information
Table 119. Bayer Description and Business Overview
Table 120. Bayer Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 121. Bayer Radiopharmaceutical Product
Table 122. Bayer Recent Development
Table 123. Eli Lilly Company Information
Table 124. Eli Lilly Description and Business Overview
Table 125. Eli Lilly Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 126. Eli Lilly Radiopharmaceutical Product
Table 127. Eli Lilly Recent Development
Table 128. Aurobindo Pharma Company Information
Table 129. Aurobindo Pharma Description and Business Overview
Table 130. Aurobindo Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 131. Aurobindo Pharma Radiopharmaceutical Product
Table 132. Aurobindo Pharma Recent Development
Table 133. Mundipharma Company Information
Table 134. Mundipharma Description and Business Overview
Table 135. Mundipharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 136. Mundipharma Radiopharmaceutical Product
Table 137. Mundipharma Recent Development
Table 138. China Isotope & Radiation Company Information
Table 139. China Isotope & Radiation Description and Business Overview
Table 140. China Isotope & Radiation Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 141. China Isotope & Radiation Radiopharmaceutical Product
Table 142. China Isotope & Radiation Recent Development
Table 143. Dongcheng Company Information
Table 144. Dongcheng Description and Business Overview
Table 145. Dongcheng Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 146. Dongcheng Radiopharmaceutical Product
Table 147. Dongcheng Recent Development
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Radiopharmaceutical Distributors List
Table 151. Radiopharmaceutical Customers List
Table 152. Radiopharmaceutical Market Trends
Table 153. Radiopharmaceutical Market Drivers
Table 154. Radiopharmaceutical Market Challenges
Table 155. Radiopharmaceutical Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Radiopharmaceutical Sales Market Share by Type in 2024 & 2031
Figure 4. Diagnostic Radiopharmaceuticals Product Picture
Figure 5. Therapeutic Radiopharmaceuticals Product Picture
Figure 6. Global Radiopharmaceutical Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Radiopharmaceutical Sales Market Share by Application in 2024 & 2031
Figure 8. Oncology Examples
Figure 9. Cardiology Examples
Figure 10. Other Examples
Figure 11. Global Radiopharmaceutical Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Radiopharmaceutical Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 14. Global Radiopharmaceutical Price Trends Growth Rate (2020-2031) & (USD/Dose)
Figure 15. Radiopharmaceutical Report Years Considered
Figure 16. Global Market Radiopharmaceutical Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Radiopharmaceutical Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 20. Europe Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 22. China Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 24. Japan Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 26. India Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. India Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 28. Global Radiopharmaceutical Revenue Share by Type (2020-2025)
Figure 29. Global Radiopharmaceutical Sales Share by Type (2026-2031)
Figure 30. Global Radiopharmaceutical Revenue Share by Type (2026-2031)
Figure 31. Global Radiopharmaceutical Revenue Share by Application (2020-2025)
Figure 32. Global Radiopharmaceutical Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Radiopharmaceutical Sales Share by Application (2026-2031)
Figure 34. Global Radiopharmaceutical Revenue Share by Application (2026-2031)
Figure 35. Global Radiopharmaceutical Sales Share by Company (2024)
Figure 36. Global Radiopharmaceutical Revenue Share by Company (2024)
Figure 37. Global 5 Largest Radiopharmaceutical Players Market Share by Revenue in Radiopharmaceutical: 2020 & 2024
Figure 38. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Radiopharmaceutical
Figure 40. Manufacturing Process Analysis of Radiopharmaceutical
Figure 41. Radiopharmaceutical Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Table 1. Global Radiopharmaceutical Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Radiopharmaceutical Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Radiopharmaceutical Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Radiopharmaceutical Sales (K Dose) by Region (2020-2025)
Table 5. Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
Table 6. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Radiopharmaceutical Revenue Share by Region (2020-2025)
Table 8. Global Radiopharmaceutical Sales (K Dose) Forecast by Region (2026-2031)
Table 9. Global Radiopharmaceutical Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Radiopharmaceutical Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Radiopharmaceutical Revenue Share Forecast by Region (2026-2031)
Table 12. Global Radiopharmaceutical Sales by Type (K Dose) & (2020-2025)
Table 13. Global Radiopharmaceutical Sales Share by Type (2020-2025)
Table 14. Global Radiopharmaceutical Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Radiopharmaceutical Price by Type (USD/Dose) & (2020-2025)
Table 16. Global Radiopharmaceutical Sales by Type (K Dose) & (2026-2031)
Table 17. Global Radiopharmaceutical Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Radiopharmaceutical Price by Type (USD/Dose) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Radiopharmaceutical Sales by Application (K Dose) & (2020-2025)
Table 21. Global Radiopharmaceutical Sales Share by Application (2020-2025)
Table 22. Global Radiopharmaceutical Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Radiopharmaceutical Price by Application (USD/Dose) & (2020-2025)
Table 24. Global Radiopharmaceutical Sales by Application (K Dose) & (2026-2031)
Table 25. Global Radiopharmaceutical Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Radiopharmaceutical Price by Application (USD/Dose) & (2026-2031)
Table 27. New Sources of Growth in Radiopharmaceutical Application
Table 28. Global Radiopharmaceutical Sales by Company (K Dose) & (2020-2025)
Table 29. Global Radiopharmaceutical Sales Share by Company (2020-2025)
Table 30. Global Radiopharmaceutical Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Radiopharmaceutical Revenue Share by Company (2020-2025)
Table 32. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)
Table 33. Global Market Radiopharmaceutical Average Price by Company (USD/Dose) & (2020-2025)
Table 34. Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Radiopharmaceutical, Product Type & Application
Table 36. Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 39. North America Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 40. North America Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 42. North America Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 43. North America Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 44. North America Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 45. North America Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 46. Europe Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 47. Europe Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 48. Europe Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 50. Europe Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 51. Europe Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 52. Europe Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 53. Europe Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 54. China Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 55. China Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 56. China Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 58. China Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 59. China Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 60. China Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 61. China Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 62. Japan Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 63. Japan Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 64. Japan Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 66. Japan Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 67. Japan Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 68. Japan Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 69. Japan Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 70. India Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)
Table 71. India Radiopharmaceutical Sales Market Share by Company (2020-2025)
Table 72. India Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Radiopharmaceutical Revenue Market Share by Company (2020-2025)
Table 74. India Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)
Table 75. India Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 76. India Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)
Table 77. India Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 78. Cardinal Health Company Information
Table 79. Cardinal Health Description and Business Overview
Table 80. Cardinal Health Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Cardinal Health Radiopharmaceutical Product
Table 82. Cardinal Health Recent Development
Table 83. GE Healthcare Company Information
Table 84. GE Healthcare Description and Business Overview
Table 85. GE Healthcare Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. GE Healthcare Radiopharmaceutical Product
Table 87. GE Healthcare Recent Development
Table 88. Jubilant Pharma Company Information
Table 89. Jubilant Pharma Description and Business Overview
Table 90. Jubilant Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Jubilant Pharma Radiopharmaceutical Product
Table 92. Jubilant Pharma Recent Development
Table 93. Novartis Company Information
Table 94. Novartis Description and Business Overview
Table 95. Novartis Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Novartis Radiopharmaceutical Product
Table 97. Novartis Recent Development
Table 98. Curium Pharma Company Information
Table 99. Curium Pharma Description and Business Overview
Table 100. Curium Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 101. Curium Pharma Radiopharmaceutical Product
Table 102. Curium Pharma Recent Development
Table 103. SIEMENS Company Information
Table 104. SIEMENS Description and Business Overview
Table 105. SIEMENS Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 106. SIEMENS Radiopharmaceutical Product
Table 107. SIEMENS Recent Development
Table 108. Lantheus Company Information
Table 109. Lantheus Description and Business Overview
Table 110. Lantheus Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 111. Lantheus Radiopharmaceutical Product
Table 112. Lantheus Recent Development
Table 113. Bracco Imaging Company Information
Table 114. Bracco Imaging Description and Business Overview
Table 115. Bracco Imaging Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 116. Bracco Imaging Radiopharmaceutical Product
Table 117. Bracco Imaging Recent Development
Table 118. Bayer Company Information
Table 119. Bayer Description and Business Overview
Table 120. Bayer Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 121. Bayer Radiopharmaceutical Product
Table 122. Bayer Recent Development
Table 123. Eli Lilly Company Information
Table 124. Eli Lilly Description and Business Overview
Table 125. Eli Lilly Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 126. Eli Lilly Radiopharmaceutical Product
Table 127. Eli Lilly Recent Development
Table 128. Aurobindo Pharma Company Information
Table 129. Aurobindo Pharma Description and Business Overview
Table 130. Aurobindo Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 131. Aurobindo Pharma Radiopharmaceutical Product
Table 132. Aurobindo Pharma Recent Development
Table 133. Mundipharma Company Information
Table 134. Mundipharma Description and Business Overview
Table 135. Mundipharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 136. Mundipharma Radiopharmaceutical Product
Table 137. Mundipharma Recent Development
Table 138. China Isotope & Radiation Company Information
Table 139. China Isotope & Radiation Description and Business Overview
Table 140. China Isotope & Radiation Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 141. China Isotope & Radiation Radiopharmaceutical Product
Table 142. China Isotope & Radiation Recent Development
Table 143. Dongcheng Company Information
Table 144. Dongcheng Description and Business Overview
Table 145. Dongcheng Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 146. Dongcheng Radiopharmaceutical Product
Table 147. Dongcheng Recent Development
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Radiopharmaceutical Distributors List
Table 151. Radiopharmaceutical Customers List
Table 152. Radiopharmaceutical Market Trends
Table 153. Radiopharmaceutical Market Drivers
Table 154. Radiopharmaceutical Market Challenges
Table 155. Radiopharmaceutical Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Radiopharmaceutical Sales Market Share by Type in 2024 & 2031
Figure 4. Diagnostic Radiopharmaceuticals Product Picture
Figure 5. Therapeutic Radiopharmaceuticals Product Picture
Figure 6. Global Radiopharmaceutical Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Radiopharmaceutical Sales Market Share by Application in 2024 & 2031
Figure 8. Oncology Examples
Figure 9. Cardiology Examples
Figure 10. Other Examples
Figure 11. Global Radiopharmaceutical Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Radiopharmaceutical Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 14. Global Radiopharmaceutical Price Trends Growth Rate (2020-2031) & (USD/Dose)
Figure 15. Radiopharmaceutical Report Years Considered
Figure 16. Global Market Radiopharmaceutical Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Radiopharmaceutical Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 20. Europe Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 22. China Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 24. Japan Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 26. India Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. India Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)
Figure 28. Global Radiopharmaceutical Revenue Share by Type (2020-2025)
Figure 29. Global Radiopharmaceutical Sales Share by Type (2026-2031)
Figure 30. Global Radiopharmaceutical Revenue Share by Type (2026-2031)
Figure 31. Global Radiopharmaceutical Revenue Share by Application (2020-2025)
Figure 32. Global Radiopharmaceutical Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Radiopharmaceutical Sales Share by Application (2026-2031)
Figure 34. Global Radiopharmaceutical Revenue Share by Application (2026-2031)
Figure 35. Global Radiopharmaceutical Sales Share by Company (2024)
Figure 36. Global Radiopharmaceutical Revenue Share by Company (2024)
Figure 37. Global 5 Largest Radiopharmaceutical Players Market Share by Revenue in Radiopharmaceutical: 2020 & 2024
Figure 38. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Radiopharmaceutical
Figure 40. Manufacturing Process Analysis of Radiopharmaceutical
Figure 41. Radiopharmaceutical Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232